Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
Small businesses can get funding to develop better clinical diagnostics that address health inequities caused by biased tests.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: [National Institutes of Health - https://www.nih.gov]
Due Dates: January 5, 2027 (Next due date) | Standard SBIR/STTR due dates apply
Funding Amounts: Typical SBIR/STTR Phase I awards: up to $256,000 for 6-12 months; Phase II awards: up to $1.7 million for 2 years; Commercialization Readiness Pilot (CRP) and Phase IIB also available.
Summary: Supports small businesses in developing improved or alternative clinical diagnostics that address health inequities caused by current assays or point-of-care devices lacking diverse patient representation.
Key Information: Clinical trials are NOT allowed under this R41/R42 funding opportunity. Applicants must identify and address specific health disparities perpetuated by existing diagnostics.
Description
This NIH funding opportunity encourages Small Business Concerns (SBCs) to develop innovative clinical diagnostics or alternative diagnostic approaches that specifically address health disparities caused by current clinical laboratory assays and point-of-care devices. Many existing diagnostics fail to incorporate diverse patient populations, leading to health inequities. Applicants must clearly identify a diagnostic issue that perpetuates such disparities, define the problem, and propose a solution to mitigate or eliminate the disparity.
The program supports early-stage research and development under the SBIR/STTR mechanisms, including Phase I (feasibility and proof of concept) and Phase II (research and development). Additional support may be available through the Commercialization Readiness Pilot (CRP) and Phase IIB awards for advanced development and commercialization activities.
Clinical trials are not allowed under this specific R41/R42 funding opportunity.
